Aurobindo Pharma Q2 earnings:


Aurobindo Pharma has posted 13.7 percent fall in its Q2 net profit at Rs 696.7 crore versus Rs 807.2 crore and revenue was down 8.4% at Rs 5,941.9 crore versus Rs 6,483.4 crore, YoY

Earnings before interest, tax, depreciation and amortization (EBITDA) was down 17% at Rs 1,186.7 crore versus Rs 1,432.7 crore and margin at 20% versus 22.1%, YoY

Aurobindo Pharma was quoting at Rs 680.15, up Rs 7.75, or 1.15 percent on the BSE.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button